Skip to main content
logo
MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
0.5652
-0.0168 (-2.89%)
At close: Sep 25, 2026, 4:00 PM EDT
0.5652
0.00 (0.00%)
After-hours: Sep 25, 2026, 4:00 PM EDT

MDxHealth Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
27.2127.3929.5527.4326.6124.2924.7423.3222.1619.8319.419.3516.7514.712.8911.156.96.116.015.5
Revenue Growth (YoY)
2.27%12.74%19.43%17.65%20.06%22.48%27.53%20.50%32.33%34.92%50.48%73.48%142.58%140.75%114.39%102.98%21.68%20.72%40.16%28.09%
Cost of Revenue
9.3210.7710.869.569.048.799.229.048.877.776.736.86.765.995.674.933.973.263.232.93
Gross Profit
17.8916.6118.6917.8817.5715.515.5214.2813.2912.0612.6712.559.998.727.226.222.932.842.792.56
Selling, General & Admin
19.620.5219.6318.0516.1615.6615.5716.3516.4815.3915.2114.7814.6714.613.4612.378.7910.78.778.14
Research & Development
22.133.282.012.572.52.792.72.92.16-0.532.350.882.11-0.32.173.59-2.351.5
Amortization of Goodwill & Intangibles
1.261.271.251.31.321.321.331.331.121.134.49-2.24-3.17-----
Other Operating Expenses
0.140-0.21-0.83-0.560.610.44-0.01-0.04-0.01-0.19-0.01-0.060.720.230.12-0.27--0.040.07
Operating Expenses
22.9923.9223.9520.5219.4820.0920.1320.3720.4618.6718.9817.1117.7317.4316.5614.6512.110.711.089.71
Operating Income
-5.1-7.3-5.26-2.64-1.92-4.59-4.61-6.09-7.18-6.6-6.31-4.56-7.74-8.72-9.34-8.43-9.17-7.85-8.29-7.15
Interest Expense
-6.08-8.95--5.88-0.26-5.18-0.69-4.96-1.39-1.91--5.48-1.71-1.09-0.1-1.43-0.86--0.76-0.26
Interest & Investment Income
1.77.395.620.50.230.694.920.20.36-6.87-0.32-0.040.060.03--0.01
Other Non Operating Income (Expenses)
---0.94--0.02-0.62-1.14--2.12-0.49-0.34-0.330.36-0.42-0.08-0.22
EBT Excluding Unusual Items
-9.48-8.87-0.58-8.02-1.96-9.070.24-10.86-7.06-8.51-1.57-10.05-8.64-9.81-9.06-10.13-9.64-8.27-9.12-7.62
Merger & Restructuring Charges
---------------0.2-3.5----
Asset Writedown
---------------0.04-----
Other Unusual Items
---9.92--5.83--7.03--4.47--9.15--1.98-1.9-3.01--0.2-1.04-
Pretax Income
-9.48-8.87-10.5-8.02-7.79-9.07-6.79-10.86-11.53-8.51-10.72-10.05-10.63-11.71-12.31-13.63-9.83-8.27-8.08-7.62
Income Tax Expense
---1.57-0.01-0.420.140.050.33--0---0.13-0.130---
Earnings From Continuing Operations
-9.48-8.87-8.93-8.01-7.37-9.21-6.84-11.19-11.53-8.51-10.72-10.05-10.63-11.71-12.44-13.5-9.83-8.27-8.08-7.62
Earnings From Discontinued Operations
-2.05-------------------
Net Income
-11.53-8.87-8.93-8.01-7.37-9.21-6.84-11.19-11.53-8.51-10.72-10.05-10.63-11.71-12.44-13.5-9.83-8.27-8.08-7.62
Net Income to Common
-11.53-8.87-8.93-8.01-7.37-9.21-6.84-11.19-11.53-8.51-10.72-10.05-10.63-11.71-12.44-13.5-9.83-8.27-8.08-7.62
Net Income Growth (YoY)
--------------------
Shares Outstanding (Basic)
5252535052484928272727252623161714171413
Shares Outstanding (Diluted)
5252535052484928272727252623161714171413
Shares Change (YoY)
0.76%7.61%7.48%78.97%89.54%76.54%77.77%11.39%6.92%17.24%71.21%45.78%88.29%41.58%15.43%35.62%14.95%60.50%54.12%40.76%
EPS (Basic)
-0.22-0.17-0.17-0.16-0.14-0.19-0.14-0.40-0.42-0.31-0.39-0.40-0.41-0.50-0.77-0.78-0.72-0.50-0.58-0.60
EPS (Diluted)
-0.22-0.17-0.17-0.16-0.14-0.19-0.14-0.40-0.42-0.31-0.39-0.40-0.41-0.50-0.77-0.78-0.72-0.50-0.58-0.60
EPS Growth (YoY)
--------------------

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
-5.89-1.850.321.4-1.96-3.11-3.31-5.83-4.84-5.74-7.72-4.51-6.96-5.06-11.06-9.84---5.83-5.56
Free Cash Flow Per Share
-0.11-0.040.010.03-0.04-0.06-0.07-0.21-0.18-0.21-0.28-0.18-0.27-0.22-0.69-0.57---0.42-0.44
Gross Margin
65.75%60.67%63.25%65.16%66.03%63.82%62.72%61.22%59.96%60.82%65.32%64.87%59.66%59.29%56.04%55.79%42.43%46.56%46.35%46.62%
Operating Margin
-18.74%-26.67%-17.81%-9.63%-7.20%-18.89%-18.63%-26.13%-32.38%-33.30%-32.51%-23.57%-46.24%-59.30%-72.41%-75.58%-132.85%-128.59%-137.84%-130.14%
Profit Margin
-42.38%-32.38%-30.22%-29.20%-27.71%-37.91%-27.65%-47.99%-52.02%-42.91%-55.26%-51.91%-63.46%-79.65%-96.49%-121.05%-142.46%-135.44%-134.41%-138.69%
Free Cash Flow Margin
-21.64%-6.77%1.10%5.10%-7.37%-12.79%-13.38%-25.00%-21.86%-28.92%-39.81%-23.30%-41.56%-34.39%-85.76%-88.18%---96.92%-101.24%
EBITDA
-2.71-4.91-2.820.18-0.22-2.34-2.42-3.94-5.38-4.7-4.72-2.7-5.97-7.08-7.78-7.98-8.38-7.66-7.99-6.43
EBITDA Margin
-9.95%-17.94%-9.55%0.65%1.31%-9.64%-9.76%-16.91%-24.27%-23.72%-24.35%-13.93%-35.63%-48.17%-60.31%-71.57%-121.44%-125.50%-132.82%-117.07%
D&A For EBITDA
2.392.392.442.822.272.252.192.151.81.91.581.871.781.641.560.450.790.190.30.72
EBIT
-5.1-7.3-5.26-2.64-1.92-4.59-4.61-6.09-7.18-6.6-6.31-4.56-7.74-8.72-9.34-8.43-9.17-7.85-8.29-7.15
EBIT Margin
-18.74%-26.67%-17.81%-9.63%-7.20%-18.89%-18.63%-26.13%-32.38%-33.30%-32.51%-23.57%-46.24%-59.30%-72.41%-75.58%-132.85%-128.59%-137.84%-130.14%
Revenue as Reported
--------41.99--19.3516.7514.712.8911.156.96.116.015.5
SEC Filings: 10-K · 10-Q